https://www.entertainmentwiremassachusetts.com/article/910497194-editas-medicine-announces-first-quarter-2026-results-and-business-updates
Editas Medicine Announces First Quarter 2026 Results and Business Updates | Entertainment Wire...
editas medicinefirst quarter
https://www.clinicaltrialsarena.com/news/allergan-and-editas-to-assess-in-vivo-crispr-editing-to-treat-lca10/
Allergan and Editas Medicine to assess in-vivo CRISPR editing for LCA10
Aug 13, 2019 - Allergan and Editas Medicine have launched a new Phase I/II trial to assess a CRISPR-based experimental medicine for Leber congenital amaurosis 10 (LCA10).
editas medicine
https://www.massachusettsweekly.com/article/910497194-editas-medicine-announces-first-quarter-2026-results-and-business-updates
Editas Medicine Announces First Quarter 2026 Results and Business Updates | Massachusetts Weekly
Massachusetts Weekly is an online news publication focusing on the Massachusetts: The most trusted news from Massachusetts
editas medicinefirst quarter
https://robinhood.com/us/en/stocks/EDIT/
Buy or Sell Editas Medicine Stock - EDIT Stock Price Quote & News | Robinhood
View the real-time EDIT price chart on Robinhood, Editas Medicine stock live quote and latest news.
buy or selleditas medicineprice quote
https://money.mymotherlode.com/clarkebroadcasting.mymotherlode/article/gnwcq-2025-6-12-editas-medicine-reports-proprietary-targeted-lipid-nanoparticle-delivery-in-non-human-primates-enables-in-vivo-hbg12-promoter-editing-for-sickle-cell-disease-and-beta-thalassemia-at-the-european-hematology-association-2025-congress-in-june
Financial News | myMotherLode.com - Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle...
Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease...
financial newseditas medicine
https://www.fool.com/investing/2023/09/29/why-editas-medicine-stock-is-soaring-today/
Why Editas Medicine Stock Is Soaring Today | The Motley Fool
Sep 29, 2023 - Investors are cheering a big analyst upgrade for the gene-editing stock.
editas medicinestocksoaringtodaymotley
https://www.benzinga.com/quote/EDIT
Editas Medicine (EDIT) Stock Price, Quote, News & History | Benzinga
Get real-time Editas Medicine (EDIT) stock price, charts, news, and analyst ratings on Benzinga. Access forecasts, historical data, and expert insights to...
editas medicinestock pricenews historyquotebenzinga
https://www.q1productions.com/allergan-pharmaceuticals-editas-medicine-confirm-crispr-deal/
Allergan Pharmaceuticals and Editas Medicine Confirm CRISPR Deal - Q1 Productions
May 4, 2017 - Allergan and Editas Medicine have confirmed a research and development alliance under which Allergan will have exclusive access to and the right to license up...
editas medicineallerganpharmaceuticalsconfirmcrispr
https://web.freetrade.io/universe/US/EDIT
Editas Medicine Stock Price (EDIT): Chart & History | Freetrade
editas medicinestock pricechart historyfreetrade
https://www.entertainmentwiremassachusetts.com/article/910497194-editas-medicine-announces-first-quarter-2026-results-and-business-updates
Editas Medicine Announces First Quarter 2026 Results and Business Updates | Entertainment Wire...
editas medicinefirst quarter